|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,130 KRW | +0.97% |
|
-0.32% | +12.79% |
On January 25, 2024, the company announced that it has extended the offering period of common stock and convertible bonds. The transaction is now expected to close on April 19, 2024. The series 1 bonds will now mature on April 19, 2027.
The conversion claim period is from April 19, 2025 to March 19, 2027.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 3,130 KRW | +0.97% | -0.32% | 174M | ||
| 1,585 KRW | 0.00% | -0.06% | 74.87M | ||
| 1,366 KRW | -1.23% | +1.86% | 80.76M | ||
| 591 KRW | -2.31% | -3.11% | 87.48M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +12.79% | 174M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
CRYSTALGENOMICS INVITES CO., LTD. 
